ASSESSMENT OF ALBUMINURIA AND CHRONIC KIDNEY DISEASE RISK FACTORS IN DIFFERENT GENDER GROUPS

THE AIM of the study was to reveal chronic kidney disease (CKD) risk factors and degree of albuminuria (AU) in different age groups applying to Health Centers in the Moscow Region of Russia and also improvement of its association with different CKD risk factors. METHODS. 1623 subjects (390 (24%) men and 1233 (76%) women, age 18-85 years) were studied. The participants were divided into two age groups: younger participants (age 50 in men and >55 in women). AU was evaluated by dipstick test in casual urine samples. We developed questionnaire collecting information about health complaints, lifestyle, medical and family history. RESULTS. In elderly participants (age >50 in men and >55 in women) AU>30 mg/L was found in 48%, and in younger participants in 39%, р30 mg/L was significantly associated with edema (66,7%), dyspnea (63,2%), palpitation (56,4%), chest pain (83,3%), thirst (73,7%), history of proteinuria (67,5%), history of ultrasound CKD signs (47,4%), obesity (56,2%), smoking (46,4%), low physical activity (34,0%).History of hyperglycemia and diabetes, history of hypertension, hyperlipidemia, family history of CKD, family history of diabetes was associated with high level of AU in both age groups. CONCLUSION. Our data reflect high prevalence of AU>30 mg/L in elderly population. Different age groups are characterized by features of high AU risk factors, which should be taken into the national screening program.

1. Смирнов АВ, Добронравов ВА, Каюков ИГ и др. Эпидемиология и социально-экономические аспекты хронической болезни почек. Нефрология 2006; 10(1):7-13

2. Бикбов БТ, Томилина НА. Состояние заместительной терапии больных с хронической почечной недостаточностью в Российской Федерации в 1998–2007 гг. (Аналитический отчет по данным Российского регистра заместительной почечной терапии). Нефрология и диализ 2009; 11(3): 144-233

3. Xue JL, Ma JZ, Louis TA, Collins AJ. Forecast of the number of patients with end-stage renal disease in the United States to the year 2010. J Am Soc Nephrol 2001; 12:2753-2758

4. Добронравов ВА, Смирнов АВ, Драгунов СВ и др. Эпидемиология хронической болезни почек в Вологодской области. Нефрология 2004; 8(1): 36-41

5. Coresh J, Selvin E, Stevens L, Manzi J at al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298(17): 2038-2047

6. ZhangQ-L, Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: Systematic review. BMC Public Health 2008; 8:117-124

7. Добронравов ВА, Смирнов АВ, Каюков ИГ и др. Многогранная альбуминурия: аспекты клинического значения. Нефрология 2009; 13(3):33-38

8. Швецов МЮ, Бобкова ИН, Колина ИБ, Камышова ЕС. Современные принципы диагностики и лечения хронической болезни почек: методическое руководство для врачей. Шилов ЕМ, ред. Саратов, 2011

9. Ninomiya T, Kiyohara Y, Kubo M, Tanizaki Y et al. Chronic kidney disease and cardiovascular disease in a general Japanese population: the Hisayama Study. Kidney Int 2005;68:228-236

10. Muntner P, He J, Hamm L. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am SocNephrol 2002; 13:745-753

11. Yuyun M, Adler A, Wareham N. What is the evidence that microalbuminuria is a predictor of cardiovascular disease events? Curr Opin Nephrol Hypertens 2005;14:271-276

12. Locatelli F, Vecchio LD, Pozzoni P. The importance of early detection of chronic kidney disease. Nephrol Dial Transplant 2002, 17(11):2-7

13. Lindeman RD, Tobin J, Shock NW. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 1985; 33: 278-285

14. .Eriksen B, Ingebretsen O. The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age. Kidney Int 2006; 69: 375-382

15. Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS. Body mass index and risk for end-stage renal disease. Ann Intern Med 2006 3;144(1):21-28

16. Verhave JC, Hillege HZ, Burgerhof GM et al. The association between atherosclerotic risk factors and renal function in the general population. Kidney Int. 2005; 67: 1967-1973

17. Мухин НА, Моисеев ВС, Кобалава ЖД и др. Кардиоренальные взаимодействия: клиническое значение и роль в патогенезе заболеваний сердечно-сосудистой системы и почек. Тер арх2004; 6: 39-46

18. Schiepati A, Remuzzi G. Chronic renal disease as a public health problem: Epidemiology, social and economic implications. Kidney Int 2005; 68 (98): 7-10

19. de Zeeuw D, Hillege HL, de Jong PE. The kidney, a cardiovascular risk marker, and a new target for therapy. Kidney Int Suppl 2005; 98: 25-29

20. Pinto-Siersma SJ, Mulder J, Janssen WM et al. Smoking is related to albuminuria and abnormal renal function in nondiabetic persons. Ann Intern Med2000; 133: 585-591

21. Warmoth L, Regalado MM, Simoni J et al. Cigarette smoking enhances increased urine albumin excretion as a risk factor for glomerular filtration rate decline in primary hypertension. Am J Med Sci 2005; 330(3): 111-119

22. Orth SR. Smoking and the kidney. J Am Soc Nephrol 2002; 13: 1663-1672

23. Haroun NK, Jaar BG, Hoffman SC et al. Risk factors for chronic Kidney disease: a prospective study of 23.534 men and women in Washington Country, Maryland. J Am Soc Nephrol 2003; 14: 2934-2941

24. Atkins RC. The epidemiology of chronic kidney disease. Kidney Int 2005; 67 (94): 14-18

25. Смирнов АВ, Добронравов ВА, Каюков ИГ и др. Хроническая болезнь почек: основные принципы скрининга, диагностики, профилактики и подходы к лечению. Национальные рекомендации. Нефрология 2012; 16(1): 89- 115